openPR Logo
Press release

Infection Prevention Devices Market: Hospitals to Offer Lucrative Opportunities

10-04-2019 11:45 PM CET | Health & Medicine

Press release from: Transparency Market Research

Infection Prevention Devices Market

Infection Prevention Devices Market

Transparency Market Research (TMR) has published a new report on the infection prevention devices market for the forecast period of 2019 to 2027. According to the report, the global infection prevention devices market was valued at ~ US$ 15.4 Bn in 2018. The infection prevention devices market is projected to expand at a CAGR of ~ 6.0% from 2019 to 2027.

Read Report Overview -

Factors Driving the Infection Prevention Devices Market

Technological advancements in the field of life sciences and biotechnology have brought about significant changes in healthcare diagnostics, drug discovery, personalized medicines, forensic sciences, and clinical research & development. This is a major factor driving the global infection prevention devices market.

The occurrence and undesirable complications from HAIs have been well-recognized for the last several decades. The occurrence of HAIs continues to rise at an alarming rate. HAIs originally refer to those infections associated with admission in an acute-care hospital; however, presently, the term applies to infections acquired in the continuum of settings where persons receive healthcare.

These unanticipated infections develop during the course of treatment, and result in significant patient illnesses and deaths, which prolong the duration of hospital stays and necessitate additional diagnostic and therapeutic interventions. This, in turn, drives the costs already incurred by the patient’s underlying disease.

HAIs are considered an undesirable outcome, and since some are preventable, they are considered an indicator of the quality of patient care, an adverse event, and a patient safety issue. Additionally, the diagnosis of infectious and chronic diseases is a leading application of in vitro diagnostics. Lifescience reagents are integral and vital part of any diagnostic test.

Request a Sample of this Report –

Hospitals to Offer Lucrative Opportunities in the Infection Prevention Devices Market

In terms of end user, the global infection prevention devices market has been divided into hospitals, lifescience industries, clinical laboratories, and others.

The hospitals segment is expected to be a highly lucrative segment of the global infection prevention devices market during the forecast period. The hospitals segment of the infection prevention devices market is likely to be driven by the increase in the number of surgical procedures and number of patients visiting hospitals.

The global infection prevention devices market is fragmented in terms of number of players. Key players operating in the infection prevention devices market are Johnson & Johnson (DePuy Synthes), Cardinal Health, PAUL HARTMANN AG, Mölnlycke Health Care AB, 3M Healthcare. Other key players operating in the global infection prevention devices market include B. Braun Melsungen AG, Coloplast Group, Ethicon, Inc. (Johnson & Johnson), Medline Industries, Inc., Becton, Dickinson and Company, C. R. Bard, Inc. (Becton, Dickinson and Company), and Hollister Incorporated.


Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infection Prevention Devices Market: Hospitals to Offer Lucrative Opportunities here

News-ID: 1843551 • Views: 312

More Releases from Transparency Market Research

Anxiety Disorders and Depression Treatment Market Incredible Potential, Stagnant …
With anxiety disorders and depression becoming a substantial public health burden, efforts are increasingly afoot to reduce their impact. A large part of this endeavor entails the use of anxiolytics and antidepressants, which will augur well for the global anxiety disorders and depression treatment market. According to a new report published by Transparency Market Research, the global anxiety disorders and depression treatment market will log a 1.25% CAGR to go
Biological Drugs Market to Explore Emerging Trends of Coming Years
The global biological drugs market is anticipated in a report by Transparency Market Research (TMR) to gain immensely from billions of dollars of investment from pharmaceutical companies attracted to lucrative business opportunities available in biologics. In order to take large strides in their market and the prime mover advantage, pharmas such as Bristol-Myers Squibb and Eli Lilly and Company have already made massive biologics investments. Biopharma-related partnerships are said to
New Comprehensive Report on Animal Blood Plasma Products and Derivatives Market …
The global animal blood plasma products and derivatives market is has a fragmented vendor landscape due to the presence of several players, Transparency Market Research (TMR) observes. Strategic partnership, acquisitions, and mergers are key startegies that these companies have adopted to gain a stronger foothold in the market. This trend have strengthen their presence and helped for business expansion globally. Some of the key players operating in the global animal
Trending : Chronic Kidney Disease (CKD) Drugs Market Companies to Garner Burstin …
Albany, New York, June 27th, 2020: A lucrative growth curve will be charted by global chronic kidney disease drugs market over the forecast period of 2016 to 2024. Diverse factors of growth will be noted being responsible towards this growth. Transparency Market Research notes, “The compound annual growth rate of the market over the forecast period would be 3.60%. This will translate to various positive outcomes. Some of these include

All 5 Releases

More Releases for Infection

Shigella Infection (Shigellosis) Therapeutics- Pipeline Analysis 2018
Shigella infection, also known as shigellosis, is a bacterial infection caused by a family of bacteria known as shigella. The main symptom of this infection is diarrhea, and can be passed through direct contact with the bacteria in the stool. Download the sample report @ The other sign and symptoms associated with shigella infection are abdominal pain, cramps, and fever. Children between the age of two and four years are
Infection Prevention and Control
Infection control products and accessories aids in the prevention and control of hospital associated & other healthcare infections. These products range from disinfectants to sterilization equipment used in the healthcare settings. Infections needs to be controlled while injecting the drugs, during the surgery and hospital stay of a patient. In addition, infection control and preventive measures aid to avoid the most common hospital infections among the healthcare staff. Get Free 10
Infection Surveillance Solutions Market Drivers With Outlook
North America is expected to hold a dominant position in global infection surveillance solutions market due to high adoption of infection surveillance solutions by hospitals in the U.S. and Canada. For instance, in 2014, Tucson Medical Center (TMC), a U.S.-based hospital installed infection surveillance solution from RL Solutions and in 2014, Trillium Health Partners, a Canada-based hospital has installed RL Solutions’ automated infection surveillance throughout its organization. Click To Continue
Influenza B Infection Market Endeavors Growth 2025
Global Influenza B Infection Market: Snapshot Influenza B infection is considered as one of the common conditions that affects a large number of people across the globe, caused due to the influenza virus B genera of the family. The condition of influenza B infection requires proper medications and treatments in order to avoid severe complications. At present, several medicines and vaccinations are made available in order to reduce the incidence of
Gram-Negative Bacterial Infection Market - Infection-type Segmentation 2017 - 20 …
Global Gram-Negative Bacterial Infection Market: Snapshot Worldwide, antimicrobial resistance is a soaring concern for a range of diseases, especially for enteric fever, respiratory tract infections, and various infections related with gram-negative bacilli (GNB). An upsurge in antibiotic resistance is mainly due to indiscriminate and inappropriate use of antibiotics and a marked decline in the development of efficacious antimicrobial agents. According to the Centers for Disease Control and Prevention (CDC), the
Infection Surveillance Solutions Market
Infection surveillance solution helps healthcare facilities in reporting patient-associated data to the state and federal authorities. Integration of infection surveillance software with already existing networks of medical facilities and hospitals is an easy process. A recent report published by Persistence Market Research (PMR) estimates the global infection surveillance solution market to register a staggering 14.04% CAGR during the forecast- 2017 to 2025. The US$ 316.67 Mn market is likely to